Word

CYTOPE

Status

Pending

Status Code

641

Status Date

Thursday, April 11, 2024

Serial Number

79380759

Mark Type

4

Filing Date

Wednesday, July 12, 2023

Trademark Owner History

Prothena Platform Technologies Limited

Classifications

5 Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes

45 Licensing of intellectual property in the field of biotechnology

42 Research and development in the pharmaceutical and biotechnology fields

Trademark Events

Oct 12, 2023

Sn Assigned For Sect 66a Appl From Ib

Oct 13, 2023

New Application Office Supplied Data Entered

Oct 17, 2023

Application Filing Receipt Mailed

Mar 20, 2024

Assigned To Examiner

Mar 23, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Mar 23, 2024

Non-Final Action Written

Apr 11, 2024

Refusal Processed By Mpu

Apr 11, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Jul 19, 2024

New Representative At Ib Received

Apr 30, 2024

Refusal Processed By Ib